Wu T, Goriounova A, Worthington E, Wrennall J, Ghosh A, Ahmad S, et al. SPLUNC1 is a negative regulator of the Orai1 Ca2+ channel. Physiol Rep. 2022;10:e15306 pubmed publisher

Lavado García J, Díaz Maneh A, Canal Paulí N, Pérez Rubio P, Godia F, Cervera L. Metabolic engineering of HEK293 cells to improve transient transfection and cell budding of HIV-1 virus-like particles. Biotechnol Bioeng. 2021;: pubmed publisher

Morgenstern T, Park J, Fan Q, Colecraft H. A potent voltage-gated calcium channel inhibitor engineered from a nanobody targeted to auxiliary CaVβ subunits. elife. 2019;8: pubmed publisher

Guarnieri A, Towers C, Drasin D, Oliphant M, Andrysik Z, Hotz T, et al. The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L. Oncogene. 2018;37:3879-3893 pubmed publisher

Kanner S, Morgenstern T, Colecraft H. Sculpting ion channel functional expression with engineered ubiquitin ligases. elife. 2017;6: pubmed publisher

Gwozdzinska P, Buchbinder B, Mayer K, Herold S, Morty R, Seeger W, et al. Hypercapnia Impairs ENaC Cell Surface Stability by Promoting Phosphorylation, Polyubiquitination and Endocytosis of ?-ENaC in a Human Alveolar Epithelial Cell Line. Front Immunol. 2017;8:591 pubmed publisher

Liu J, Wan L, Liu J, Yuan Z, Zhang J, Guo J, et al. Cdh1 inhibits WWP2-mediated ubiquitination of PTEN to suppress tumorigenesis in an APC-independent manner. Cell Discov. 2016;2:15044 pubmed publisher

Tanksley J, Chen X, Coffey R. NEDD4L is downregulated in colorectal cancer and inhibits canonical WNT signaling. PLoS ONE. 2013;8:e81514 pubmed publisher

Gao S, Alarcon C, Sapkota G, Rahman S, Chen P, Goerner N, et al. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell. 2009;36:457-68 pubmed publisher